NovaCure ApS: Financial statements 2025
CVR: 45424820
Source: annual report 2025, Danish Business Authority
20/02/2025 – 31/12/2025
NovaCure ApS (CVR 45424820) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -59,667 and a net result of DKK -164,809. Equity in the 2025 report amounted to DKK -34,809.
- Gross Profit
- DKK -59,667
- Profit/Loss
- DKK -164,809
- Equity
- DKK -34,809
- Total Assets
- DKK 28,843
- Employees
- 0
Official annual report
How creditworthy is NovaCure ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
As of February 20, 2025, Beierholm Godkendt Revisionspartnerselskab has been appointed auditor of NovaCure ApS.
As of February 20, 2025, Iben Soffy Gammelgaard is registered as director of NovaCure ApS.
As of February 20, 2025, Kenneth Willander is registered as director of NovaCure ApS.
As of February 20, 2025, Iben Soffy Gammelgaard is registered as an owner of NovaCure ApS with an ownership share of 50%.
As of February 20, 2025, Kenneth Willander is registered as an owner of NovaCure ApS with an ownership share of 50%.
NovaCure ApS was founded on February 20, 2025.
About NovaCure ApS
NovaCure ApS is a Danish company of the type Anpartsselskab based in Aalborg SV, founded in 2025. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Iben Soffy Gammelgaard and Kenneth Willander. The company is owned by Iben Soffy Gammelgaard and Kenneth Willander. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -59,667 and a net result of DKK -164,809. Equity in the 2025 report amounted to DKK -34,809.